524654 Stock Overview Engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteNatural Capsules Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Natural Capsules Historical stock prices Current Share Price ₹280.20 52 Week High ₹384.00 52 Week Low ₹255.00 Beta 0.53 1 Month Change 5.56% 3 Month Change -6.60% 1 Year Change -21.47% 3 Year Change -18.79% 5 Year Change 405.78% Change since IPO 709.83%
Recent News & Updates
Natural Capsules Limited to Report Q3, 2025 Results on Feb 12, 2025 Feb 05
Second quarter 2025 earnings released: ₹0.60 loss per share (vs ₹1.67 profit in 2Q 2024) Nov 14
Natural Capsules Limited to Report Q2, 2025 Results on Nov 12, 2024 Nov 04
New minor risk - Shareholder dilution Sep 28
Investor sentiment improves as stock rises 16% Aug 28
First quarter 2025 earnings released: EPS: ₹0.65 (vs ₹1.96 in 1Q 2024) Aug 15 See more updates
Natural Capsules Limited to Report Q3, 2025 Results on Feb 12, 2025 Feb 05
Second quarter 2025 earnings released: ₹0.60 loss per share (vs ₹1.67 profit in 2Q 2024) Nov 14
Natural Capsules Limited to Report Q2, 2025 Results on Nov 12, 2024 Nov 04
New minor risk - Shareholder dilution Sep 28
Investor sentiment improves as stock rises 16% Aug 28
First quarter 2025 earnings released: EPS: ₹0.65 (vs ₹1.96 in 1Q 2024) Aug 15
Natural Capsules Limited to Report Q1, 2025 Results on Aug 13, 2024 Aug 05 Natural Capsules Limited announced that it expects to receive INR 292.13344 million in funding from Acme Pumps And Power Projects Limited, Chhatisgarh Investments Limited, Pcg Finvest Limited, Pratibha Endeavor Private Limited and other investors Jul 27
Full year 2024 earnings released: EPS: ₹5.97 (vs ₹19.93 in FY 2023) Jul 05
Natural Capsules Limited, Annual General Meeting, Jul 26, 2024 Jul 04
Investor sentiment improves as stock rises 16% Jun 17
Full year 2024 earnings released: EPS: ₹12.46 (vs ₹19.89 in FY 2023) May 22
Natural Capsules Limited to Report Q4, 2024 Results on May 21, 2024 May 17
Third quarter 2024 earnings released: EPS: ₹1.29 (vs ₹5.68 in 3Q 2023) Feb 10
Natural Capsules Limited to Report Q3, 2024 Results on Feb 09, 2024 Feb 02
Second quarter 2024 earnings released: EPS: ₹1.67 (vs ₹6.85 in 2Q 2023) Nov 11
Natural Capsules Limited to Report Q2, 2024 Results on Nov 09, 2023 Nov 03
First quarter 2024 earnings released: EPS: ₹1.96 (vs ₹7.43 in 1Q 2023) Aug 10
Natural Capsules Limited to Report Q1, 2024 Results on Aug 09, 2023 Aug 03
Upcoming dividend of ₹1.00 per share at 0.3% yield Jul 13
Full year 2023 earnings released: EPS: ₹19.89 (vs ₹19.84 in FY 2022) Jul 08
Natural Capsules Limited, Annual General Meeting, Jul 28, 2023 Jul 06
Investor sentiment improves as stock rises 16% Jun 21
Investor sentiment deteriorates as stock falls 20% Jun 02
Full year 2023 earnings released: EPS: ₹18.87 (vs ₹19.84 in FY 2022) May 30
Natural Capsules Limited Recommends Dividend May 28
Natural Capsules Limited Recommends Dividend May 27
Natural Capsules Limited to Report Q4, 2023 Results on May 26, 2023 May 20
Third quarter 2023 earnings released: EPS: ₹5.68 (vs ₹5.85 in 3Q 2022) Feb 14
Natural Capsules Limited to Report Q3, 2023 Results on Feb 13, 2023 Feb 04
Investor sentiment improved over the past week Dec 30
Less than half of directors are independent Nov 16
Natural Capsules Limited to Report Q2, 2023 Results on Oct 28, 2022 Oct 22
Investor sentiment improved over the past week Sep 07
Upcoming dividend of ₹1.00 per share Sep 02
First quarter 2023 earnings released: EPS: ₹7.43 (vs ₹3.35 in 1Q 2022) Aug 12
Natural Capsules Approves Resignation of Mr. Anjan Kumar as Independent Director Aug 11
Investor sentiment improved over the past week Aug 11
Natural Capsules Limited, Annual General Meeting, Sep 20, 2022 Aug 11
Investor sentiment deteriorated over the past week Jun 13
Third quarter 2022 earnings released: EPS: ₹5.85 (vs ₹2.59 in 3Q 2021) May 11
Investor sentiment deteriorated over the past week May 11 Natural Capsules Limited Recommends Dividend
Natural Capsules Limited to Report Q4, 2022 Results on May 09, 2022 May 03
Less than half of directors are independent Apr 27
Investor sentiment improved over the past week Apr 19
Investor sentiment improved over the past week Feb 15
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 10
Investor sentiment improved over the past week Dec 22
Investor sentiment improved over the past week Dec 07
Second quarter 2022 earnings released: EPS ₹4.18 (vs ₹1.91 in 2Q 2021) Nov 01
First quarter 2022 earnings released: EPS ₹3.35 (vs ₹3.98 in 1Q 2021) Aug 09
Investor sentiment improved over the past week Jul 16
Upcoming dividend of ₹1.00 per share Jun 29
Full year 2021 earnings released: EPS ₹11.09 (vs ₹1.38 in FY 2020) Jun 27
Full year 2021 earnings released: EPS ₹10.99 (vs ₹1.38 in FY 2020) Jun 02
Natural Capsules Limited Recommends Final Dividend Jun 01
Investor sentiment improved over the past week May 31
Investor sentiment improved over the past week Feb 26
New 90-day high: ₹117 Feb 26
Natural Capsules Limited to Report Q3, 2021 Results on Jan 25, 2021 Jan 17
New 90-day high: ₹90.05 Dec 30
Market bids up stock over the past week Nov 18
Insider recently bought ₹3.6m worth of stock Nov 16
Natural Capsules Limited to Report Q2, 2021 Results on Nov 07, 2020 Nov 01
New 90-day high - ₹53.35 Aug 11
First quarter earnings released Aug 10
Upcoming Dividend of ₹0.60 Per Share Aug 05 Shareholder Returns 524654 IN Pharmaceuticals IN Market 7D 5.4% 3.4% 1.6% 1Y -21.5% 19.3% 5.5%
See full shareholder returns
Return vs Market: 524654 underperformed the Indian Market which returned 5.5% over the past year.
Price Volatility Is 524654's price volatile compared to industry and market? 524654 volatility 524654 Average Weekly Movement 5.9% Pharmaceuticals Industry Average Movement 6.1% Market Average Movement 6.3% 10% most volatile stocks in IN Market 9.1% 10% least volatile stocks in IN Market 4.3%
Stable Share Price: 524654 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524654's weekly volatility (6%) has been stable over the past year.
About the Company Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal certified gelatin, fast release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form.
Show more Natural Capsules Limited Fundamentals Summary How do Natural Capsules's earnings and revenue compare to its market cap? 524654 fundamental statistics Market cap ₹2.90b Earnings (TTM ) ₹21.62m Revenue (TTM ) ₹1.61b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 524654 income statement (TTM ) Revenue ₹1.61b Cost of Revenue ₹849.96m Gross Profit ₹756.18m Other Expenses ₹734.56m Earnings ₹21.62m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
Earnings per share (EPS) 2.09 Gross Margin 47.08% Net Profit Margin 1.35% Debt/Equity Ratio 38.0%
How did 524654 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/07 03:44 End of Day Share Price 2025/02/07 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Natural Capsules Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Anil Burra FirstCall Research